Delcath Systems (DCTH)

Delcath Systems (DCTH) Stock Price & Analysis


DCTH Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.34 - $7.99
Previous Close$7.29
Average Volume (3M)53.44K
Market Cap
Enterprise Value$62.81M
Total Cash (Recent Filing)$24.27M
Total Debt (Recent Filing)$9.66M
Price to Earnings (P/E)-2.0
Aug 17, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.73
Shares Outstanding10,620,813
10 Day Avg. Volume90,428
30 Day Avg. Volume53,442
Standard Deviation0.22
Financial Highlights & Ratios
Price to Book (P/B)-6.47
Price to Sales (P/S)129.69
Price to Cash Flow (P/CF)-5.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue20.20
Enterprise Value/Gross Profit30.90
Enterprise Value/Ebitda-1.86
Price Target Upside110.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Delcath Systems’s price range in the past 12 months?
Delcath Systems lowest stock price was $2.34 and its highest was $7.99 in the past 12 months.
    What is Delcath Systems’s market cap?
    Currently, no data Available
    When is Delcath Systems’s upcoming earnings report date?
    Delcath Systems’s upcoming earnings report date is Aug 17, 2023 which is in 74 days.
      How were Delcath Systems’s earnings last quarter?
      Delcath Systems released its earnings results on May 12, 2023. The company reported -$0.7 earnings per share for the quarter, missing the consensus estimate of -$0.612 by -$0.088.
        Is Delcath Systems overvalued?
        According to Wall Street analysts Delcath Systems’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Delcath Systems pay dividends?
          Delcath Systems does not currently pay dividends.
          What is Delcath Systems’s EPS estimate?
          Delcath Systems’s EPS estimate is -$0.52.
            How many shares outstanding does Delcath Systems have?
            Delcath Systems has 10,620,813 shares outstanding.
              What happened to Delcath Systems’s price movement after its last earnings report?
              Delcath Systems reported an EPS of -$0.7 in its last earnings report, missing expectations of -$0.612. Following the earnings report the stock price went down -0.826%.
                Which hedge fund is a major shareholder of Delcath Systems?
                Among the largest hedge funds holding Delcath Systems’s share is Deerfield Management Company, LP. It holds Delcath Systems’s shares valued at N/A.


                  Delcath Systems Stock Smart Score

                  The Delcath Systems stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Delcath Systems

                  Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes CHEMOSAT and Melphalan Hydrochloride for Injection, which is a proprietary product used with the Delcath Hepatic Delivery System. The company was founded in August 1988 and is headquartered in New York, NY.


                  Top 5 ETFs holding DCTH

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold DCTH. The ETFs are listed according to market value of DCTH within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Brainstorm Cell Therapeutics
                  Cyclacel Pharmaceuticals
                  Infinity Pharma

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis